| Diagnostic value of labial minor salivary gland biopsy for Sjögren's syndrome: a systematic review D Guellec, D Cornec, S Jousse-Joulin, T Marhadour, P Marcorelles, ... Autoimmunity reviews 12 (3), 416-420, 2013 | 196 | 2013 |
| Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren’s syndrome M Le Goff, D Cornec, S Jousse-Joulin, D Guellec, S Costa, T Marhadour, ... Arthritis research & therapy 19, 1-10, 2017 | 115 | 2017 |
| Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort GC Alegria, D Guellec, X Mariette, JE Gottenberg, E Dernis, JJ Dubost, ... RMD open 2 (1), e000179, 2016 | 111 | 2016 |
| Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial J Diaz-Manera, PS Kishnani, H Kushlaf, S Ladha, T Mozaffar, V Straub, ... The Lancet Neurology 20 (12), 1012-1026, 2021 | 96 | 2021 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 86 | 2021 |
| Effect of tocilizumab on disease activity in patients with active polymyalgia rheumatica receiving glucocorticoid therapy: a randomized clinical trial V Devauchelle-Pensec, G Carvajal-Alegria, E Dernis, C Richez, ... Jama 328 (11), 1053-1062, 2022 | 56 | 2022 |
| ANCA-associated vasculitis in patients with primary Sjögren's syndrome: detailed analysis of 7 new cases and systematic literature review D Guellec, E Cornec-Le Gall, M Groh, E Hachulla, A Karras, P Charles, ... Autoimmunity reviews 14 (8), 742-750, 2015 | 53 | 2015 |
| Relationship between hip dysplasia, pain, and osteoarthritis in a cohort of patients with hip symptoms J Morvan, R Bouttier, B Mazieres, E Verrouil, J Pouchot, AC Rat, ... The Journal of rheumatology 40 (9), 1583-1589, 2013 | 46 | 2013 |
| Time-course of ultrasound abnormalities of major salivary glands in suspected Sjögren's syndrome P Gazeau, D Cornec, S Jousse-Joulin, D Guellec, A Saraux, ... Joint Bone Spine 85 (2), 227-232, 2018 | 44 | 2018 |
| Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab A Huwart, F Garrigues, S Jousse-Joulin, T Marhadour, D Guellec, ... Arthritis Research & Therapy 20, 1-8, 2018 | 41 | 2018 |
| Is there specific neurological disorders of primary Sjögren's syndrome? GC Alegria, D Guellec, V Devauchelle-Pensec, A Saraux Joint Bone Spine 82 (2), 86-89, 2015 | 38 | 2015 |
| ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19 M Etienne, N Ettalhaoui, AG Everding, M Evers, I Fabre, M Fabre, ... Scientific data 9 (1), 454, 2022 | 37 | 2022 |
| The value of open-source clinical science in pandemic response: lessons from ISARIC A Abbas, SA Abdukahil, NN Abdulkadir, R Abe, L Abel, L Absil, S Acharya, ... The Lancet infectious diseases 21 (12), 1623-1624, 2021 | 37 | 2021 |
| Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID‐19 patients Y Yazdanpanah, French COVID Cohort Investigators and Study Group, ... Journal of Medical Virology 93 (4), 2149-2159, 2021 | 33 | 2021 |
| Refining myositis associated with primary Sjögren’s syndrome: data from the prospective cohort ASSESS R Felten, M Giannini, B Nespola, B Lannes, D Levy, R Seror, O Vittecoq, ... Rheumatology 60 (2), 675-681, 2021 | 30 | 2021 |
| Localized myofascial inflammation revealed by magnetic resonance imaging in recent-onset polymyalgia rheumatica and effect of tocilizumab therapy JP Laporte, F Garrigues, A Huwart, S Jousse-Joulin, T Marhadour, ... The Journal of Rheumatology 46 (12), 1619-1626, 2019 | 26 | 2019 |
| Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable V Devauchelle-Pensec, L Saraux, JM Berthelot, M De Bandt, D Cornec, ... Rheumatology 57 (4), 666-670, 2018 | 26 | 2018 |
| Eosinophilia predicts poor clinical outcomes in recent-onset arthritis: results from the ESPOIR cohort D Guellec, M Milin, D Cornec, GJ Tobon, T Marhadour, S Jousse-Joulin, ... RMD open 1 (1), e000070, 2015 | 23 | 2015 |
| Efficacy and safety of avalglucosidase alfa in patients with late-onset Pompe disease after 97 weeks: a phase 3 randomized clinical trial PS Kishnani, J Diaz-Manera, A Toscano, PR Clemens, S Ladha, ... JAMA neurology 80 (6), 558-567, 2023 | 17 | 2023 |
| Osteoarthritis epidemiology and risk factors T Marhadour, D Guellec, A Saraux, V Devauchelle-Pensec, ... Soins; la Revue de Reference Infirmiere, 28-29, 2012 | 17 | 2012 |
Alain SarauxU1227Verified email at chu-brest.fr
